Pear Therapeutics
Pear Therapeutics appears in 1 markets tracked by Meridian Consensus across 1 industry (Healthcare). Aggregate market exposure is $87.1B, computed as the sum of (share × market size) across every appearance.
Its strongest position is United States Digital Cognitive Assessment and Digital Therapeutics Market at 1.9% share in a market growing at 5.0% CAGR. Average share across all tracked markets is 1.9%, indicating a diversified participant footprint.
Each market page below carries the full Porter Five Forces, SWOT, regional sub-data, regulatory landscape, and competitor table the operator competes against. Use the related-operator rail at the bottom of the page to triangulate Pear Therapeutics against the peers it actually overlaps with in those segments.
Market positions
Avg share 1.9% · sorted by exposure| Market | Market size | Share | Exposure |
|---|---|---|---|
| United States Digital Cognitive Assessment and Digital Therapeutics Market | $4537.9B | 1.9% |
Explore adjacent markets
Each market page surfaces Porter Five Forces, SWOT, country analysis, patent filings, regulatory signals, and more, verified against SEC filings, FRED macro series, and trade-association benchmarks.
Operators that compete with Pear Therapeutics
Peers that show up alongside Pear Therapeutics in the markets above. Ordered by how many overlapping markets they share — the top of the list is who the operator competes against most directly.
- 1 sharedBiogenTop overlap · United States Digital Cognitive Assessment and Digital Therapeutics
- 1 sharedAkili InteractiveTop overlap · United States Digital Cognitive Assessment and Digital Therapeutics
- 1 sharedBig HealthTop overlap · United States Digital Cognitive Assessment and Digital Therapeutics
- Click TherapeuticsTop overlap · United States Digital Cognitive Assessment and Digital Therapeutics